Biostime 1112

Biostime 1112

Postby winston » Wed Aug 20, 2014 9:53 am

not vested

<Research Report> BIOSTIME (01112.HK) initiated Buy with target $59 by BofA Merrill Lynch

In the latest research report, BofA Merrill Lynch initiated the Buy rating for BIOSTIME (01112.HK), with target price $59, representing 2015 forecast P/E of 21.5 times, as the Bank sees the effective channel strategy and O2O initiative, the potential to become all-around baby product provider, coupled with the management power and solid past results.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Wed Aug 20, 2014 10:14 am

not vested

<Research Report>BIOSTIME (01112.HK) rated Overweight with target cut to $65 by HSBC
Apr 24, 2014

According to the latest research report by HSBC, the impacts brought by the price cut of BIOSTIME (01112.HK) were greater than projected, thus target price was reduced from $85 to $65, and 2014/2015 earnings estimates were trimmed by 17% and 21% respectively.

Nevertheless, the bank believed the price cut will only lead to one-off influences, anticipating sales and profit will recover in the second half of 2014, thanks to lower base and the introduction of infant products in 4Q.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Wed Aug 20, 2014 10:17 am

not vested

<Result Ann>BIOSTIME (01112.HK) 2013 net profit up 10%
Mar 26, 2014

BIOSTIME (01112.HK) announced that for 2013, the revenue rose 34.9% yearly to RMB4.561 billion; net profit rose 10.4% to RMB821 million, representing EPS of RMB1.37.

A final dividend of HK44 cents, coupled with special dividend of HK33 cents, was declared.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Wed Aug 20, 2014 2:05 pm

[b]<Result Ann>BIOSTIME (01112.HK) 1H net profit up 4.9%[/b]

BIOSTIME (01112.HK) announced that for the first half year as of the end of June, the[b] revenue rose 6.2% yearly[/b] to RMB2.189 billion;

[b]Net profit rose 4.9% [/b]to RMB312 million, representing EPS of 52 fen.

An interim dividend of HK26 cents was declared.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Wed Aug 20, 2014 2:17 pm

not vested

BIOSTIME (01112.HK): diaper business will be new growth driver
Mar 27, 2014

BIOSTIME (01112.HK) Chairman Luo Fei said diaper business will be a new growth driver for the group in the future, as Chinese couples who are a single child in the family can give birth to the second child.

BIOSTIME set up a joint venture company which is engaged in diaper business in early 2014, Luo said, adding it is now a right time to diversify the company's product mix.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Wed Aug 20, 2014 2:19 pm

not vested

BIOSTIME (01112.HK) forms JV to produce baby diapers
Jan 12, 2014

BIOSTIME (01112.HK) announced that it has formed a joint venture with Hangzhou Coco Healthcare to be engaged in the business of manufacture, sale, import and export of baby diapers.

The entire equity interest of the joint venture will be owned as to 60% by Coco Healthcare and 40% by Biostime Hong Kong.

The registered capital is RMB100 million and the company will make cash capital contribution of RMB40 million to the joint venture.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Wed Aug 20, 2014 6:44 pm

vested

BIOSTIME (01112.HK) sees better gross margin in 2H

The gross margin of BIOSTIME (01112.HK) -4.050 (-10.916%) Short selling $78.95M; Ratio 15.096% declined from 66.4% to 61.5% in 1H.

CFO Cao Wenhui explained the reduction was attributable to the changes in product mix, slower growth in high-end products, the depreciation of RMB and the 1-year rebate program for customers.

However, he projected gross margin will improve in 2H, as the rebate program is approaching an end and the retail price will resume normality.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Thu Aug 28, 2014 2:05 pm

not vested

<Research Report>BIOSTIME (01112.HK) kept at Neutral, target trimmed to $33 - Citi
Aug 22, 2014

BIOSTIME (01112.HK)'s interim profit receded 30% which was mainly challenged by the competition on the supreme segment and a worse-than-expected impact on E-commerce business, Citibank said in its latest report.

The company's 2H2014 earnings are expected to recede 20%.

To reflect the slower sales and lower margin, the bank cut estimates for the company's 2014 and 2015 earnings by 37% and 43% respectively, and revised downward its target price from $64.54 to $33 with the rating kept at Neutral.

Besides the top pick MENGNIU DAIRY (02319.HK), the bank also preferred CH MODERN D (01117.HK).

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Thu Aug 28, 2014 2:06 pm

not vested

<Research Report>BIOSTIME (01112.HK) downgraded to Hold, target cut to $36.2 - Deutsche
Aug 21, 2014

According to the latest research report by Deutsche Bank, BIOSTIME (01112.HK) was downgraded to Hold from Buy.

Target price was slashed from $66 to $36.2.

2014-2016 EPS estimates were lowered by 26.6%/42.6%/43.1% respectively.

The bank considered BIOSTIME has stronger competitive edges and better sales channels than other baby formula brands, yet the unfavorable industrial factors will only be alleviated in 1H 2015.

Moreover, the interim results of BIOSTIME were far below expectation, thus it will take time to restore confidence of investors.

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Re: Biostime 1112

Postby winston » Thu Aug 28, 2014 2:07 pm

not vested

<Research Report>BIOSTIME (01112.HK) target cut to $39.6, removed from Asia-Pacific CL Buy list - G Sachs
Aug 21, 2014

In the latest research report, Goldman Sachs removed BIOSTIME (01112.HK) from the Asia Pacific Conviction List of Buy, as it had underestimated the pressure of competition in the industry.

The Buy rating is maintained, with target price cut from $68 to $39.6. ~

Source: AAStocks Financial News
It's all about "how much you made when you were right" & "how little you lost when you were wrong"
User avatar
winston
Billionaire Boss
 
Posts: 118530
Joined: Wed May 07, 2008 9:28 am

Next

Return to A to B

Who is online

Users browsing this forum: No registered users and 9 guests